-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QOdW35rsPOJeJdPg+QCCmbQmVau0JM8kH5C4Euqdso6vFwvSDwAzeDtHY/ijHA0r FmjYRukRVWAIvXJT4gI79Q== 0001016193-09-000024.txt : 20091006 0001016193-09-000024.hdr.sgml : 20091006 20091006130037 ACCESSION NUMBER: 0001016193-09-000024 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20091006 DATE AS OF CHANGE: 20091006 EFFECTIVENESS DATE: 20091006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-PATH HOLDINGS INC CENTRAL INDEX KEY: 0001133818 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-MISCELLANEOUS SHOPPING GOODS STORES [5940] IRS NUMBER: 870652870 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-124542 FILM NUMBER: 091107568 BUSINESS ADDRESS: STREET 1: 3293 HARRISON BOULEVARD STE 230 CITY: OGDEN STATE: UT ZIP: 84403 BUSINESS PHONE: 8013995500 MAIL ADDRESS: STREET 1: 3293 HARRISON BOULEVARD STE 230 CITY: OGDEN STATE: UT ZIP: 84403 FORMER COMPANY: FORMER CONFORMED NAME: OGDEN GOLF CO CORP DATE OF NAME CHANGE: 20010205 D 1 primary_doc.xml X0603 D LIVE 0001133818 BIO-PATH HOLDINGS INC 3293 HARRISON BOULEVARD STE 230 OGDEN UT 84403 8013995500 UTAH OGDEN GOLF CO CORP Corporation true Peter H Nielsen 3293 Harrison Blvd Ste 230 Ogden UT 84403 Executive Officer Director Promoter Douglas P Morris 3293 Harrison Blvd Ste 230 Ogden UT 84403 Executive Officer Director Promoter Thomas Garrison 3293 Harrison Blvd Ste 230 Ogden UT 84403 Director Gillian Ivers-Read 3293 Harrison Blvd Ste 230 Ogden UT 84403 Director Biotechnology No Revenues 06 false true false true false 0 ACAP Financial 07731 None None 57 West 200 South Suite 202 Salt Lake City UT 84101 AZ UT 650000 0 650000 Units of two shares of common stock and two warrants. false 0 65000 true 0 Plus one share of stock for each five units sold. 0 true Clinical Trials: $400,000 Working Capital: $175,000 false BIO-PATH HOLDINGS INC /s/ Douglas P. Morris Vice President 2009-10-06 -----END PRIVACY-ENHANCED MESSAGE-----